Description
An inhibitor of FAS-II, blocking fatty acid synthesis in S. aureus and E. coli with IC50 values of 11.4 and 35.3 µg/ml, respectively; inhibits the growth of S. aureus and premeable E. coli strains with MICs ranging from 0.2-0.4 µg/ml
Formal name: (6R,16R)-10,12-dichloro-6,7,9,16-tetrahydro-11,13,15-trihydroxy-3-methoxy-1,6,9,9-tetramethyl-6,16-epoxy-14H-anthra[2,3-d][1]benzoxocin-14-one
Synonyms: (―)-Bischloroanthrabenzoxocinone|BABX
Molecular weight: 543.4
CAS: 866022-28-8
Purity: ≥99%
Formulation: A light orange residue
Product Type|Biochemicals|Antibiotics||Product Type|Biochemicals|Natural Products||Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Endocrinology & Metabolism|Hormones & Receptors|FXRs & LXRs||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Bacterial Diseases